CEL-SCI CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
CEL-SCI CORPORATION (CVM) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $0 for the 12-month period ending 2023-09-30, per its 10-K filed 2023-12-21.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2023-12-21
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2023-09-30 was $0.00.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2023-06-30 was $0.00.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2023-03-31 was $0.00.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2022-12-31 was $0.00.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2023 was $0.00.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2022 was $0.00.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2021 was $0.00.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2020 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | $0.00 derived: sum of 2 quarters · filed 2023-12-21 | $0.00 derived: sum of 3 quarters · filed 2023-12-21 | $0.00 10-K · filed 2023-12-21 |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-10 | $0.00 derived: sum of 2 quarters · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $0.00 derived: sum of 4 quarters · filed 2023-12-21 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 3 quarters · filed 2023-12-21 | $0.00 derived: sum of 4 quarters · filed 2023-12-21 |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-14 | $0.00 derived: sum of 2 quarters · filed 2023-12-21 | $0.00 derived: sum of 3 quarters · filed 2023-12-21 | $0.00 derived: sum of 4 quarters · filed 2023-12-21 |
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | $0.00 derived: sum of 2 quarters · filed 2023-12-21 | $0.00 derived: sum of 3 quarters · filed 2023-12-21 | $0.00 10-K · filed 2023-12-21 |
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-10 | $0.00 derived: sum of 2 quarters · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $0.00 derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 3 quarters · filed 2023-05-12 | $0.00 derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-14 | $0.00 derived: sum of 2 quarters · filed 2023-02-14 | $0.00 derived: sum of 3 quarters · filed 2023-02-14 | $0.00 derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-27 | $0.00 derived: sum of 2 quarters · filed 2022-12-27 | $0.00 derived: sum of 3 quarters · filed 2022-12-27 | $0.00 10-K · filed 2022-12-27 |
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $0.00 derived: sum of 2 quarters · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | $0.00 derived: sum of 4 quarters · filed 2021-12-21 |
| 2021-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-17 | $0.00 10-Q · filed 2021-05-17 | $0.00 derived: sum of 3 quarters · filed 2021-12-21 | $0.00 derived: sum of 4 quarters · filed 2021-12-21 |
| 2020-12-31 | $0.00 10-Q · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-12-21 | $0.00 derived: sum of 3 quarters · filed 2021-12-21 | $0.00 derived: sum of 4 quarters · filed 2021-12-21 |
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-12-21 | $0.00 derived: sum of 2 quarters · filed 2021-12-21 | $0.00 derived: sum of 3 quarters · filed 2021-12-21 | $0.00 10-K · filed 2021-12-21 |
| 2020-06-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2020-12-31 | $0.00 derived: sum of 2 quarters · filed 2020-12-31 | $0.00 10-Q/A · filed 2020-12-31 | $0.00 derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-03-31 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2020-12-30 | $0.00 10-Q/A · filed 2020-12-30 | $0.00 derived: sum of 3 quarters · filed 2021-05-17 | $0.00 derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $0.00 10-Q/A · filed 2020-12-30 | $0.00 derived: sum of 2 quarters · filed 2021-05-17 | $0.00 derived: sum of 3 quarters · filed 2021-05-17 | $0.00 derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-09-30 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2021-05-17 | $0.00 derived: sum of 2 quarters · filed 2021-05-17 | $0.00 derived: sum of 3 quarters · filed 2021-05-17 | $0.00 10-Q · filed 2021-05-17 |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $0.00 derived: sum of 2 quarters · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $0.00 derived: sum of 4 quarters · filed 2019-12-23 |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $0.00 10-Q · filed 2019-05-14 | $0.00 derived: sum of 3 quarters · filed 2019-12-23 | $0.00 derived: sum of 4 quarters · filed 2019-12-23 |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-12-23 | $0.00 derived: sum of 3 quarters · filed 2019-12-23 | $0.00 derived: sum of 4 quarters · filed 2019-12-23 |
| 2018-09-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | $0.00 derived: sum of 2 quarters · filed 2019-12-23 | $0.00 derived: sum of 3 quarters · filed 2019-12-23 | $0.00 10-K/A · filed 2019-12-23 |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $0.00 derived: sum of 2 quarters · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $0.00 derived: sum of 4 quarters · filed 2018-12-19 |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | $0.00 10-Q · filed 2018-05-15 | $0.00 derived: sum of 3 quarters · filed 2018-12-19 | $744.26K derived: sum of 4 quarters · filed 2018-12-19 |
| 2017-12-31 | $0.00 10-Q · filed 2018-02-12 | $0.00 derived: sum of 2 quarters · filed 2018-12-19 | $744.26K derived: sum of 3 quarters · filed 2018-12-19 | $2.35M derived: sum of 4 quarters · filed 2018-12-19 |
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-12-19 | $744.26K derived: sum of 2 quarters · filed 2018-12-19 | $2.35M derived: sum of 3 quarters · filed 2018-12-19 | $4.67M 10-K · filed 2018-12-19 |
| 2017-06-30 | $744.26K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | $2.35M derived: sum of 2 quarters · filed 2017-12-11 | $4.67M 10-Q/A · filed 2017-12-11 | $6.21M derived: sum of 4 quarters · filed 2017-12-29 |
| 2017-03-31 | $1.61M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-12-11 | $3.92M 10-Q/A · filed 2017-12-11 | $5.47M derived: sum of 3 quarters · filed 2017-12-29 | $7.58M derived: sum of 4 quarters · filed 2017-12-29 |
| 2016-12-31 | $2.32M 10-Q/A · filed 2017-12-11 | $3.86M derived: sum of 2 quarters · filed 2017-12-29 | $5.98M derived: sum of 3 quarters · filed 2017-12-29 | $5.98M derived: sum of 4 quarters · filed 2017-12-29 |
| 2016-09-30 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | $3.66M derived: sum of 2 quarters · filed 2017-12-29 | $3.66M derived: sum of 3 quarters · filed 2017-12-29 | $8.72M 10-K · filed 2017-12-29 |
| 2016-06-30 | $2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $2.11M derived: sum of 2 quarters · filed 2016-08-09 | $7.17M 10-Q · filed 2016-08-09 | $7.17M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $5.06M 10-Q · filed 2016-05-10 | $5.06M derived: sum of 3 quarters · filed 2017-12-11 | |
| 2015-12-31 | $5.06M 10-Q · filed 2016-02-09 | $5.06M derived: sum of 2 quarters · filed 2017-12-11 | ||
| 2015-09-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $8.00M 10-K/A · filed 2017-12-11 | ||
| 2015-06-30 | $8.00M 10-Q · filed 2015-08-07 | |||
| 2014-12-31 | $0.00 10-Q · filed 2015-02-06 | |||
| 2014-09-30 | $7.79M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |